Trials / Completed
CompletedNCT03282357
Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds in China
Evaluation of the Effectiveness and Safety of Radiesse for the Correction of Nasolabial Folds
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 181 (actual)
- Sponsor
- Merz North America, Inc. · Industry
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the effectiveness and safety of Radiesse for the correction of nasolabial folds (NLFs).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiesse injectable implant (dermal filler) | Subdermal injection. |
| DEVICE | Restylane injectable implant (dermal filler) | Subdermal injection |
Timeline
- Start date
- 2017-07-27
- Primary completion
- 2018-07-17
- Completion
- 2018-11-30
- First posted
- 2017-09-13
- Last updated
- 2021-02-23
- Results posted
- 2021-02-23
Locations
4 sites across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03282357. Inclusion in this directory is not an endorsement.